LXRXbenzinga

Lexicon Pharmaceuticals Q4 EPS $(0.09) Beats $(0.12) Estimate, Sales $26.55M Beat $6.48M Estimate

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on March 6, 2025 by benzinga

    Lexicon Pharmaceuticals Q4 EPS $(0.09) Beats $(0.12) Estimate, Sales $26.55M Beat $6.48M Estimate | LXRX Stock News | Candlesense